Category: ANTI - DIABETIC

ETHAMCIP 250 Tablet contains Ethamsylate B.P. 250mg as its active ingredient, manufactured by Cipla Ltd. Ethamsylate is a synthetic hemostatic agent prescribed primarily for the prevention and reduction of abnormal bleeding. It acts by increasing the ability of platelets to stick together and helping form blood clots, thereby stabilizing capillary walls and reducing blood loss from tiny vessels.

This tablet is typically used in conditions such as heavy or abnormal menstrual bleeding, dysfunctional uterine bleeding, and to prevent or control bleeding during, before, or after delicate surgical procedures. ETHAMCIP 250 may also be indicated in other situations where there is increased risk of blood loss, including some bleeding disorders.

The medication should be taken exactly as directed by your doctor, with dosage and duration depending on the specific condition being treated. It can be taken with or without food, preferably at the same time each day to maintain consistent blood levels.

Common side effects include nausea, headache, skin rash, vomiting, and diarrhea, which are generally mild and temporary. Inform your physician if you have any history of liver, heart, or kidney disease, or if you experience any persistent or severe reactions. ETHAMCIP 250 should not be used in patients with allergy to ethamsylate or certain blood disorders unless specifically prescribed.

If you miss a dose, take it as soon as you remember; do not double up doses. Before starting this medication, disclose all your existing medical conditions and medicines to your doctor for safe administration. Use in pregnancy or breastfeeding should be discussed with your healthcare provider.

ETHAMCIP 250 Tablet is an effective option to reduce blood loss and prevent complications associated with excessive bleeding when taken under medical supervision.

ETHAMCIP 500 Tablet contains Ethamsylate B.P. 500mg as its active ingredient, and is manufactured by Cipla Ltd. Ethamsylate is classified as a synthetic hemostatic drug, used to prevent and control excessive bleeding from small blood vessels (capillaries) in various clinical situations.

It works primarily by increasing platelet adhesion and aggregating ability, which promotes the formation of stable blood clots and reinforces capillary walls. This helps to shorten bleeding time and reduce overall blood loss, making ETHAMCIP 500 particularly important in cases of heavy menstrual bleeding (menorrhagia), dysfunctional uterine bleeding, post-surgery bleeding, trauma, and other medical conditions associated with excessive capillary blood loss. It may also be used to reduce bleeding risk during and after delicate surgical procedures.

The tablet should be taken precisely as prescribed by a doctor. The typical adult regimen is one 500mg tablet, usually 2–3 times daily, though dose and duration vary based on the clinical context. ETHAMCIP 500 can be taken with or without food, but taking it with food helps minimize possible stomach upset.

Common side effects are generally mild and include headache, nausea, vomiting, diarrhea, skin rashes, and dizziness. Patients should notify their doctor of any persistent or bothersome symptoms, or if they have previous heart, liver, or kidney conditions. ETHAMCIP 500 should be avoided in those allergic to ethamsylate and is generally not recommended during pregnancy or breastfeeding unless explicitly advised by your physician.

Patients with known bleeding disorders, a history of seizures, or certain blood diseases should use ETHAMCIP 500 only under strict medical supervision. Always inform your doctor of other medications and supplements you are taking. In case of missed dose, take it as soon as remembered unless nearly time for the next; never double doses.

ETHAMCIP 500 Tablet is a clinically proven option for the rapid and effective management of excessive bleeding, when administered according to medical advice.

GLYCELIPTIN contains teneligliptin, a modern oral antidiabetic (DPP-4 inhibitor) for the treatment of type 2 diabetes mellitus. It is usually prescribed when diet, exercise, or other oral medicines are not sufficient for blood sugar control.

How GLYCELIPTIN Works

• Teneligliptin inhibits the DPP-4 enzyme, raising incretin hormones in the body.

• This action increases insulin release after meals, decreases glucagon (a blood sugar-raising hormone), and helps lower overall and post-meal blood glucose.

• It is effective as monotherapy or in combination with other antidiabetic drugs, and does not generally cause weight gain or very low blood sugar (unless combined with sulfonylureas or insulin).

Uses

• Primary: Treatment of type 2 diabetes mellitus in adults (as part of a comprehensive plan including diet and exercise).

• Combination therapy: Used with other oral antidiabetics or insulin when additional blood sugar control is needed.

Benefits

• Effective at improving glycemic control and lowering HbA1c

• Lower risk of hypoglycemia compared to many alternatives

• Convenient once-daily dosage, with or without food.

Common Side Effects

• Hypoglycemia (when used with other medicines), headache, dizziness, constipation, diarrhea, fever, upper respiratory symptoms.

• Most side effects are mild and transient—see a doctor if persistent or serious

Directions & Precautions

• Take exactly as prescribed, ideally at the same time each day

• Lifestyle (diet, exercise) should be continued alongside medicine for best results

• Not for use in type 1 diabetes, pregnancy/breastfeeding, or severe liver/kidney impairment without medical advice

• Notify doctor of all concurrent medicines

GLYCELIPTIN is a prescription anti-diabetic tablet for type 2 diabetes—not banned, widely available, and effective when used as part of a comprehensive diabetes plan.

GLYCELIPTIN-M is a fixed-dose combination tablet for the management of type 2 diabetes mellitus. It combines teneligliptin (a DPP-4 inhibitor) and metformin (a biguanide), each enhancing blood sugar control through complementary mechanisms.

How GLYCELIPTIN-M Works

• Metformin decreases glucose production in the liver and improves the body’s response to insulin, lowering fasting and post-meal blood sugar levels.

• Teneligliptin blocks the DPP-4 enzyme, increasing incretin hormones, enhancing insulin release, and decreasing glucagon secretion, especially after meals.

Uses

• Type 2 diabetes mellitus: For adults whose blood sugars are not adequately controlled by diet, exercise, or metformin alone.

• May be used as first-line therapy in combination with lifestyle changes, or as add-on/step-up therapy when monotherapy is insufficient.

Benefits

• Better control of fasting and post-meal glucose than with single-agent therapy

• Significant reductions in HbA1c, improved glycemic control, and reduced risk of diabetes complications.

• Low risk of weight gain or hypoglycemia (unless combined with insulin/sulfonylureas).

Common Side Effects

• Mild and short-term: Diarrhea, nausea, constipation, abdominal pain, bloating, headache, loss of appetite.

• Hypoglycemia risk rises if used with other antidiabetics

• Rare: Lactic acidosis (with metformin, especially in severe kidney/liver disease), vitamin B12 deficiency

Directions & Precautions

• Take with food to minimize GI upset, once or twice daily as prescribed.

• Not for use in type 1 diabetes, diabetic ketoacidosis, severe renal/hepatic/cardiac impairment, or those with known allergies to components.

• Caution in elderly, alcoholics, and during dehydration/illness—inform your doctor

• Continue diet, exercise, and regular monitoring

GLYCELIPTIN-M is a prescription combination for type 2 diabetes, not banned in India, and is widely available as a cost-effective, clinically proven treatment.